Polysaccharide from Cyclocarya paliurus ameliorates chronic obstructive pulmonary disease through the inflammatory pathway regulated by the AhR/NF-κB pathway | Synapse
March 3, 2026
Polysaccharide from Cyclocarya paliurus ameliorates chronic obstructive pulmonary disease through the inflammatory pathway regulated by the AhR/NF-κB pathway
Puntos clave
Polysaccharide treatment significantly decreases inflammation in chronic obstructive pulmonary disease.
A dose-dependent response shows a reduction in inflammatory cytokines by 40% in treated samples.
Chemical analysis of polysaccharides suggests the activation of the AhR/NF-κB pathway leads to improved outcomes.
Potential therapeutic applications for managing chronic obstructive pulmonary disease are highlighted by these findings.